MiR-25-3p promotes proliferation of triple-negative breast cancer by directly targeting B-cell translocation gene 2 (26) and promotes osteoclast differentiation by regulating the expression of nuclear factor I X (27). This evidence concerns the gene NFIX and triple-negative breast carcinoma.